MSB 3.21% $1.13 mesoblast limited

Cynata claiming their cells far superior to MSB's, page-12

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    "I didn't release that MSB licenced JCR as a result of a patent breach".

    Pretty sure you are correct. JCR had a partnership with Osiris, there's never been any suggestion it was a result of patent breach.

    The Takeda "partnership" is the result of patent infringement.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.